Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;10(5-6):129-139.
doi: 10.1177/1759720X18773726. Epub 2018 May 17.

Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria

Fabian Proft  1 , Denis Poddubnyy  2
Affiliations
Review

Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria

Fabian Proft et al. Ther Adv Musculoskelet Dis. 2018 Jun.

Abstract

Development of the Assessment in Spondyloarthritis International Society (ASAS) classification criteria for axial spondyloarthritis (SpA) was one of the major breakthroughs in the field over the past decade. Despite some concerns related to the specificity of the criteria, they stimulated research into the early stage of the disease. This resulted in major advances in the understanding of the course of the disease, revealing predictors of progression, improvement in early diagnosis and treatment in axial SpA. In this review, we summarize the recent developments resulting from the introduction of the ASAS classification criteria for axial SpA and the implications for research and clinical practice.

Keywords: ASAS; Axial spondyloarthritis; ankylosing spondylitis; classification criteria; diagnosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare no conflict of interests in preparing this article.

Figures

Figure 1.
Figure 1.
The spectrum of spondyloarthritis (SpA) and overlap (cross-sectional and longitudinal) between different SpA forms. IBD, inflammatory bowel disease.
Figure 2.
Figure 2.
Assessment in Spondyloarthritis International Society (ASAS) classification criteria for axial spondyloarthritis (SpA). *Sacroiliitis on imaging refers to definite radiographic sacroiliitis according to the modified New York criteria or active sacroiliitis on magnetic resonance imaging according to the ASAS consensus definition. CRP, C-reactive protein; HLA-B27, human leucocyte antigen-B27; IBD, inflammatory bowel disease; NSAIDs, nonsteroidal anti-inflammatory drugs.
Figure 3.
Figure 3.
Treatment algorithm for axial spondyloarthritis (SpA) based on the Assessment in Spondyloarthritis International Society/European League Against Rheumatism and American College of Rheumatology/Spondylitis Association of America/SpA Research and Treatment Network recommendations. bDMARDs, biologic disease-modifying antirheumatic drugs; csDMARDs, conventional synthetic disease-modifying antirheumatic drugs; IL-17A, interleukin-17A; NSAIDs, nonsteroidal anti-inflammatory drugs; TNF, tumour necrosis factor.
Figure 4.
Figure 4.
(a) Approval status and year of approval for biological disease-modifying antirheumatic drugs (bDMARDs) by the European Medicines Agency for axial spondyloarthritis (SpA) in the EU and a number of other countries. (b) Approval status and year of approval for bDMARDs by the US Food and Drug Administration for SpA in the USA.
See this image and copyright information in PMC

References

    1. Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet 2017; 390: 73–84. - PubMed
    1. Rudwaleit M, van der Heijde D, Landewe R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011; 70: 25–31. - PubMed
    1. Raychaudhuri SP, Deodhar A. The classification and diagnostic criteria of ankylosing spondylitis. J Autoimmun 2014; 48–49: 128–133. - PubMed
    1. Reveille JD, Weisman MH. The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci 2013; 345: 431–436. - PMC - PubMed
    1. Reveille JD, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol 2001; 13: 265–272. - PubMed

LinkOut - more resources